# Jürgen Floege

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jurgen-floege/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,445 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 104 |
| i10-index | 384 |
| Last Known Institution | RWTH Aachen University |
| OpenAlex ID | https://openalex.org/A5001027249 |
| ORCID iD | 0000-0002-8763-828X |
| Works | 674 |

## Researcher papers

Showing 12 of 30.

- [KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-glomerular-diseases/)
- [Cardiovascular Disease in Chronic Kidney Disease](https://scholariq.org/papers/cardiovascular-disease-in-chronic-kidney-disease/)
- [Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis](https://scholariq.org/papers/joint-european-league-against-rheumatism-and-european-renal-association-european/)
- [Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study](https://scholariq.org/papers/association-of-low-fetuin-a-ahsg-concentrations-in-serum-with-cardiovascular/)
- [The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification](https://scholariq.org/papers/the-serum-protein-2-heremans-schmid-glycoprotein-fetuin-a-is-a-systemically/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Decoding myofibroblast origins in human kidney fibrosis](https://scholariq.org/papers/decoding-myofibroblast-origins-in-human-kidney-fibrosis/)
- [Intensive Supportive Care plus Immunosuppression in IgA Nephropathy](https://scholariq.org/papers/intensive-supportive-care-plus-immunosuppression-in-iga-nephropathy/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Renal fibrosis: novel insights into mechanisms and therapeutic targets](https://scholariq.org/papers/renal-fibrosis-novel-insights-into-mechanisms-and-therapeutic-targets/)
- [Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy](https://scholariq.org/papers/effect-of-oral-methylprednisolone-on-clinical-outcomes-in-patients-with-iga/)
- [KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS](https://scholariq.org/papers/kdigo-2024-clinical-practice-guideline-for-the-management-of-lupus-nephritis/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Researcher university

- [RWTH Aachen University](https://scholariq.org/institutions/rwth-aachen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.